BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 496920)

  • 1. Relative inability of mother and child to convert phenylalanine of tyrosine--a possible cause of nonspecific mental retardation.
    Fujimoto A; Crawford R; Bessman SP
    Biochem Med; 1979 Jun; 21(3):271-6. PubMed ID: 496920
    [No Abstract]   [Full Text] [Related]  

  • 2. Diet, genetics, and mental retardation interaction between phenylketonuric heterozygous mother and fetus to produce nonspecific diminution of IQ: evidence in support of the justification hypothesis.
    Bessman SP; Williamson ML; Koch R
    Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1562-6. PubMed ID: 274741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amino acid imbalance as a pathogenetic factor in mental retardation (author's transl)].
    Fekete G
    Klin Wochenschr; 1974 May; 52(6):276-82. PubMed ID: 4408538
    [No Abstract]   [Full Text] [Related]  

  • 4. [Some indices of phenylalanine and tyrosine metabolism in children with phenylketonuria].
    D'iachkova AIa; Lebedev BV
    Vopr Okhr Materin Det; 1969; 14(7):29-32. PubMed ID: 5367726
    [No Abstract]   [Full Text] [Related]  

  • 5. Children of mothers with phenylketonuria.
    Yu JS; O'Halloran MT
    Lancet; 1970 Jan; 1(7640):210-2. PubMed ID: 4189007
    [No Abstract]   [Full Text] [Related]  

  • 6. Glutamine depletion in phenylketonuria. A possible cause of the mental defect.
    Perry TL; Hansen S; Tischler B; Bunting R; Diamond S
    N Engl J Med; 1970 Apr; 282(14):761-6. PubMed ID: 5416968
    [No Abstract]   [Full Text] [Related]  

  • 7. Phenylalanine metabolism and intellectual functioning among carriers of phenylketonuria and hyperphenylalaninaemia.
    Ford RC; Berman JL
    Lancet; 1977 Apr; 1(8015):767-71. PubMed ID: 66568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on conversion of phenylalanine to tyrosine in phenylpyruvic oligophrenia.
    WALLACE HW; MOLDAVE K; MEISTER A
    Proc Soc Exp Biol Med; 1957 Apr; 94(4):632-3. PubMed ID: 13431902
    [No Abstract]   [Full Text] [Related]  

  • 9. Phenylalanine and tyrosine metabolism in phenylketonuria heterozygotes: influence of different phenylalanine hydroxylase mutations.
    Spada M; Dianzani I; Bonetti G; Biondi A; Leone L; Giannattasio S; Ponzone A
    J Inherit Metab Dis; 1998 Jun; 21(3):236-9. PubMed ID: 9686365
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracellular phenylalanine and tyrosine concentrations in 19 heterozygotes for phenylketonuria (PKU) and 26 normals. Do the higher values in heterozygotes explain their lowered intellectual level?
    Thalhammer O; Lubec G; Königshofer H
    Hum Genet; 1979 Jul; 49(3):333-6. PubMed ID: 478540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The offspring of phenylketonuric women.
    Howell RR; Stevenson RE
    Soc Biol; 1971 Sep; 18():S19-29. PubMed ID: 4945474
    [No Abstract]   [Full Text] [Related]  

  • 12. 5-hydroxyindole levels in the blood and CSF in Down's syndrome, phenylketonuria and severe mental retardation.
    Tu J; Partington MW
    Dev Med Child Neurol; 1972 Aug; 14(4):457-66. PubMed ID: 4262081
    [No Abstract]   [Full Text] [Related]  

  • 13. The justification theory: the essential nature of the non-essential amino acids.
    Bessman SP
    Nutr Rev; 1979 Jul; 37(7):209-20. PubMed ID: 384302
    [No Abstract]   [Full Text] [Related]  

  • 14. Mental retardation in four offspring of a hyperphenylalaninemic mother.
    Brown ES; Waisman HA
    Pediatrics; 1971 Sep; 48(3):401-10. PubMed ID: 5094341
    [No Abstract]   [Full Text] [Related]  

  • 15. Injury and insult--considerations of the neuropathological aetiology of mental subnormality.
    Cowie V
    Br J Psychiatry; 1980 Oct; 137():305-12. PubMed ID: 7004555
    [No Abstract]   [Full Text] [Related]  

  • 16. New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction.
    Smith I; Clayton BE; Wolff OH
    Lancet; 1975 May; 1(7916):1108-11. PubMed ID: 49470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Some experiments on phenylalanine- and tyrosine metabolism in a patient with phenylpyruvic oligophrenia].
    HAMANN I
    Maandschr Kindergeneeskd; 1956 Jan; 24(1):28-36. PubMed ID: 13308279
    [No Abstract]   [Full Text] [Related]  

  • 18. From the Clinical Conference St. Louis Children's Hospital. Phenylketonuria. Diagnostic and therapeutic dilemma.
    Kahn LI
    Clin Pediatr (Phila); 1970 May; 9(5):263-71. PubMed ID: 5445064
    [No Abstract]   [Full Text] [Related]  

  • 19. Causes for high phenylalanine with normal tyrosine in newborn screening programs.
    Berman JL; Cunningham GC; Day RW; Ford R; Hsia DY
    Am J Dis Child; 1969 Jan; 117(1):54-65. PubMed ID: 5782533
    [No Abstract]   [Full Text] [Related]  

  • 20. Phenylketonuria or phenylpyruvic oligophrenia in the rat: behavioural and biochemical correlates.
    Perez VJ
    J Ment Defic Res; 1965 Sep; 9(3):170-82. PubMed ID: 5892858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.